Abstract
Compared to malignant tumors, benign tumors of the liver are encountered rarely in daily practice, although their true incidence is probably not low [1]. This is because they are either asymptomatic and not discovered or they are not biopsied and left unresected. However, ultrasonographic imaging often may show benign tumors in the liver. Some of these tumors are true neoplasms, while others are tumor-like masses (Table 16.1) [2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AFP:
-
Alpha-fetoprotein
- AML:
-
Angiomyolipoma
- BDA:
-
Bile duct adenoma
- CEA:
-
Carcinoembryonic antigen
- c-myc:
-
Cancer-myelocytomatosis
- ELISA:
-
Enzyme-linked immunosorbent assay
- FNH:
-
Focal nodular hyperplasia
- HCA:
-
Hepatocellular adenoma
- HCC:
-
Hepatocellular carcinoma
- HMB45:
-
Human melanoma black 45
- HNF-1:
-
Hepatocyte nuclear factor 1
- IL6ST:
-
Interleukin 6 signal transducer
- IPN:
-
Intraductal papillary neoplasm
- IPT:
-
Inflammatory pseudotumor
- L-FABP:
-
Liver fatty acid binding protein
- LMS:
-
Larva migrans syndrome
- MCN:
-
Mucinous cystic neoplasm
- p53:
-
53-kilodalton protein
- PECOMA:
-
Perivascular epithelioid cell tumors
- PIVKA2:
-
Protein induced by vitamin K absence or antagonist-2
References
Goodman ZD. Benign tumors of the liver. In: Okuda K, Ishak KG, editors. Neoplasms of the liver. Berlin: Springer; 1988. p. 105–25.
Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.
Shimizu M, Miura J, Itoh H, Saitoh Y. Hepatic giant cavernous hemangioma with microangiopathic hemolytic anemia and consumption coagulopathy. Am J Gastroenterol. 1990;85:1411–3.
Kim GE, Thung SN, Tsui WM, Ferrell LD. Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int. 2006;26:334–8.
Lehmann FS, Beglinger C, Schnabel K, Terraciano L. Progressive development of diffuse liver angiomatosis. J Hepatol. 1999;30:951–4.
Ryan RM, Buelow B, Mather C, et al. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Hum Pathol. 2016;54:143–51.
Song JS, Kim YN, Moon WS. A sclerosing hemangioma of the liver. Clin Mol Hepatol. 2013;19:426–30.
Yamashita Y, Shimada M, Taguchi K, Gion T, Hasegawa H, Utsunomiya T, et al. Hepatic sclerosing hemangioma mimicking a metastatic liver tumor: report of a case. Surg Today. 2000;30:849–52.
Lee VT, Magnaye M, Tan HW, Thng CH, Ooi LL. Sclerosing haemangioma mimicking hepatocellular carcinoma. Singap Med J. 2005;46:140–3.
Makhlouf HR, Ishak KG. Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver. 2002;22:70–8.
Stocker JT, Ishak KG. Focal nodular hyperplasia of the liver: a study of 21 pediatric cases. Cancer. 1981;48:336–45.
Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X chromosome inactivation. Hepatology. 1997;26:891–5.
Wanless I, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5:1194–200.
Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441–54.
Paradis V, Benzekri A, Dargère D, Bièche I, Laurendeau I, Vilgrain V, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. 2004;126:1323–9.
Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.
Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.
Govindarajan S, Peters RL. The bile duct adenoma. A lesion distinct from Meyenburg complex. Arch Pathol Lab Med. 1984;108:922–4.
Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma: a study of 152 cases. Am J Surg Pathol. 1988;12:708–15.
Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol. 1996;20:858–64.
Colombari R, Tsui WM. Biliary tumors of the liver. Semin Liver Dis. 1995;15:402–13.
Tsui WM, Loo KT, Chow LT, Tse CC. Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver. Am J Surg Pathol. 1993;17:186–92.
Varnholt H, Vauthey JN, Dal Cin P, Marsh Rde W, Bhathal PS, Hughes NR, et al. Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. Am J Surg Pathol. 2003;27:693–8.
Arnason T, Borger DR, Corless C, Hagen C, Iafrate AJ, Makhlouf H, Misdraji J, Sapp H, Tsui WM, Wanless IR, Zuluaga Toro T, Lauwers GY. Biliary adenofibroma of liver: morphology, tumor genetics, and outcomes in 6 cases. Am J Surg Pathol. 2017;41:499–505.
Thai E, Dalla Valle R, Evaristi F, Silini EM. A case of biliary adenofibroma with malignant transformation. Pathol Res Pract. 2016;212:468–70.
Thompson SM, Zendejas-Mummert B, Hartgers ML, Venkatesh SK, Smyrk TC, Mahipal A, Smoot RL. Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor. J Gastrointest Oncol. 2016;7:E107–12.
Albores-Saavedra J, Hoang MP, Murakata LA, Sinkre P, Yaziji H. Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver. Am J Surg Pathol. 2001;25:956–60.
Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer. 1977;39:322–38.
Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer. 1985;56:1434–45.
Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 1994;18:1078–91.
Subramony C, Herrera GA, Turbat-Herrera EA. Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis. Arch Pathol Lab Med. 1993;117:1036–42.
Terada T, Kitamura Y, Ohta T, Nakanuma Y. Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas. Virchows Arch. 1997;430:37–40.
Kim YI, Kim ST, Lee GK, Choi BI. Papillary cystic tumor of the liver. Cancer. 1990;65:2740–6.
Nakanuma Y, Sasaki M, Terada T, Harada K. Intrahepatic peribiliary glands of humans. II. Pathological spectrum. J Gastroenterol Hepatol. 1994;9:80–6.
Madden JJ Jr, Smith GW. Multiple biliary papillomatosis. Cancer. 1974;34:1316–20.
Chen TC, Nakanuma Y, Zen Y, Chen MF, Jan YY, Yeh TS, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651–8.
Kim YS, Myung SJ, Kim SY, Kim HJ, Kim JS, Park ET, et al. Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy. 1998;30:763–7.
Tsui WM, Lam PW, Mak CK, Pay KH. Fine-needle aspiration cytologic diagnosis of intrahepatic biliary papillomatosis (intraductal papillary tumor): report of three cases and comparative study with cholangiocarcinoma. Diagn Cytopathol. 2000;22:293–8.
Nakanuma Y, Sasaki M, Ishikawa A, Tsui W, Chen TC, Huang SF. Biliary papillary neoplasm of the liver. Histol Histopathol. 2002;17:851–61.
Rambaud S, Nores JM, Meeus F, Paolaggi JA. Malignant papillomatosis of the bile ducts: a new indication for liver transplantation? Am J Gastroenterol. 1989;84:448–9.
Goodman ZD, Ishak KG. Angiomyolipomas of the liver. Am J Surg Pathol. 1984;8:745–50.
Nonomura A, Mizukami Y, Kadoya M, Matsui O, Shimizu K, Izumi R. Angiomyolipoma of the liver: a collective review. J Gastroenterol. 1994;29:95–105.
Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.
Bonetti F, Pea M, Martignoni G, Zamboni G. The perivascular epithelioid cell and related lesions. Adv Anat Pathol. 1997;4:343–58.
Nguyen TT, Gormann B, Shileds D, Goodman Z. Malignant hepatic angiomyolipoma: report of case and review of literature. Am J Surg Pathol. 2008;32:793–8.
Anthony PP, Telesinghe PU. Inflammatory pseudotumour of the liver. J Clin Pathol. 1986;39:761–8.
Horiuchi R, Uchida T, Kojima T, Shikata T. Inflammatory pseudotumor of the liver. Clinicopathologic study and review of the literature. Cancer. 1990;65:1583–90.
Shek TW, Ng IO, Chan KW. Inflammatory pseudotumor of the liver. Report of four cases and review of the literature. Am J Surg Pathol. 1993;17:231–8.
Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.
Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor, with respect to IgG4-related disease. Mod Pathol. 2007;20:884–94.
Selves J, Meggetto F, Brousset P, Voigt JJ, Pradère B, Grasset D, et al. Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol. 1996;20:747–53.
Su LD, Atayde-Perez A, Sheldon S, Fletcher JA, Weiss SW. Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol. 1998;11:364–8.
Gonzalez-Ojeda A, Rodriguez-Alcantar DA, Arenas-Marquez H, Sanchez Perez-Verdia E, Chavez-Perez R, Alvarez-Quintero R, et al. Retained foreign bodies following intra-abdominal surgery. Hepatogastroenterology. 1999;46:808–12.
Kalovidouris A, Kehagias D, Moulopoulos L, Gouliamos A, Pentea S, Vlahos L. Abdominal retained surgical sponges: CT appearance. Eur Radiol. 1999;9:1407–10.
Shepherd NA, Lee G. Solitary necrotic nodules of the liver simulating hepatic metastases. J Clin Pathol. 1983;36:1181–3.
Berry CL. Solitary “necrotic nodule” of the liver: a probable pathogenesis. J Clin Pathol. 1985;38:1278–80.
Sundaresan M, Lyons B, Akosa AB. “Solitary” necrotic nodules of the liver: an aetiology reaffirmed. Gut. 1991;32:1378–80.
Tsui WM, Yuen RW, Chow LT, Tse CC. Solitary necrotic nodule of the liver: parasitic origin? J Clin Pathol. 1992;45:975–8.
Feldmeier H, Schuster A. Mini review: hookworm-related cutaneous larva migrans. Eur J Clin Microbiol Infect Dis. 2012;31:915–8.
Liu Q, Li MW, Wang ZD, Zhao GH, Zhu XQ. Human sparganosis, a neglected food borne zoonosis. Lancet Infect Dis. 2015;15:1226–35.
Macpherson CN. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int J Parasitol. 2013;43:999–1008.
Maruyama H, Nawa Y, Noda S, Mimori T, Choi WY. An outbreak of visceral larva migrans due to Ascaris suum in Kyushu, Japan. Lancet. 1996;347:1766–7.
Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265–72.
Pinelli E, Herremans T, Harms MG, Hoek D, Kortbeek LM. Toxocara and Ascaris seropositivity among patients suspected of visceral and ocular larva migrans in the Netherlands: trends from 1998 to 2009. Eur J Clin Microbiol Infect Dis. 2011;30:873–9.
Baldisserotto M, Conchin CF, Soares Mda G, Araujo MA, Kramer B. Ultrasound findings in children with toxocariasis: report on 18 cases. Pediatr Radiol. 1999;29:316–9.
Ishibashi H, Shimamura R, Hirata Y, Kudo J, Onizuka H. Hepatic granuloma in toxocaral infection: role of ultrasonography in hypereosinophilia. J Clin Ultrasound. 1992;20:204–10.
Parsons JC, Bowman DD, Grieve RB. Tissue localization of excretory-secretory antigens of larval Toxocara canis in acute and chronic murine toxocariasis. Am J Trop Med Hyg. 1986;27:492–8.
Kaplan KJ, Goodman ZD, Ishak KG. Eosinophilic granuloma of the liver: a characteristic lesion with relationship to visceral larva migrans. Am J Surg Pathol. 2001;25:1316–21.
de Savigny DH, Volle A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol. 1979;32:284–8.
Magnaval JF, Fabre R, Maurieres P, Charlet JP, de Larrard B. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res. 1991;77:697–702.
Khuroo MS. Ascariasis. Gastroenterol Clin North Am. 1996;25:553–77.
Acknowledgment
Prof. Alex Y. Chang was a coauthor of the first edition of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Tsui, W.M.S., Mori, T., Iwai, M. (2019). Liver Tumor I: Benign Tumors and Tumor-Like Lesions. In: Hashimoto, E., Kwo, P., Suriawinata, A., Tsui, W., Iwai, M. (eds) Diagnosis of Liver Disease. Springer, Singapore. https://doi.org/10.1007/978-981-13-6806-6_16
Download citation
DOI: https://doi.org/10.1007/978-981-13-6806-6_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6805-9
Online ISBN: 978-981-13-6806-6
eBook Packages: MedicineMedicine (R0)